GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions
Sign Up to like & getrecommendations! Published in 2025 at "Clinical and Translational Science"
DOI: 10.1111/cts.70262
Abstract: Glucagon‐like peptide‐1 agonists (GLP‐1A) are increasingly prescribed to treat obesity and type 2 diabetes mellitus in children and adolescents. Emerging evidence suggesting neuropsychiatric effects presents an opportunity for pediatric psychopharmacology but requires careful consideration of… read more here.
Keywords: opportunities cautions; psychopharmacology opportunities; agonists pediatric; psychopharmacology ... See more keywords